Less is more for the next generation of CAR T cells
When researchers from Penn Medicine (including two of our grantees, Dr. Saar Gill and Dr. Marco Ruella!) found that many patients with B-cell acute lymphoblastic leukemia (ALL) treated with the investigational chimeric antigen receptor (CAR) T cell therapy targeting the CD22 antigen didn’t respond, they went back to the drawing board to determine why. They […]
Read more